Literature DB >> 30706399

Surgical Methods for Inner Ear Gene Delivery in Neonatal Mouse.

Kevin Isgrig1, Wade W Chien2,3.   

Abstract

Inner ear gene therapy offers great potential as a treatment for hearing loss and dizziness. The surgical method used to deliver gene therapy into the inner ear is a critical step in determining the success of inner ear gene therapy. Here we describe two commonly used surgical methods for gene delivery in neonatal mouse inner ear: the round window approach and the posterior semicircular canal approach. Both of these approaches are effective at delivering gene therapy to the neonatal mouse inner ear.

Entities:  

Keywords:  Dizziness; Gene therapy; Hearing loss; Inner ear; Posterior semicircular canal; Round window

Mesh:

Year:  2019        PMID: 30706399      PMCID: PMC7094763          DOI: 10.1007/978-1-4939-9065-8_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Tmc gene therapy restores auditory function in deaf mice.

Authors:  Charles Askew; Cylia Rochat; Bifeng Pan; Yukako Asai; Hena Ahmed; Erin Child; Bernard L Schneider; Patrick Aebischer; Jeffrey R Holt
Journal:  Sci Transl Med       Date:  2015-07-08       Impact factor: 17.956

Review 2.  Gene therapy for sensorineural hearing loss.

Authors:  Wade W Chien; Elyssa L Monzack; Devin S McDougald; Lisa L Cunningham
Journal:  Ear Hear       Date:  2015-01       Impact factor: 3.570

3.  Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G.

Authors:  Alice Emptoz; Vincent Michel; Andrea Lelli; Omar Akil; Jacques Boutet de Monvel; Ghizlene Lahlou; Anaïs Meyer; Typhaine Dupont; Sylvie Nouaille; Elody Ey; Filipa Franca de Barros; Mathieu Beraneck; Didier Dulon; Jean-Pierre Hardelin; Lawrence Lustig; Paul Avan; Christine Petit; Saaid Safieddine
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-23       Impact factor: 11.205

4.  Perilymph Kinetics of FITC-Dextran Reveals Homeostasis Dominated by the Cochlear Aqueduct and Cerebrospinal Fluid.

Authors:  A N Salt; R M Gill; J J Hartsock
Journal:  J Assoc Res Otolaryngol       Date:  2015-03-24

5.  Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy.

Authors:  Omar Akil; Rebecca P Seal; Kevin Burke; Chuansong Wang; Aurash Alemi; Matthew During; Robert H Edwards; Lawrence R Lustig
Journal:  Neuron       Date:  2012-07-26       Impact factor: 17.173

6.  Gene Therapy Restores Balance and Auditory Functions in a Mouse Model of Usher Syndrome.

Authors:  Kevin Isgrig; Jack W Shteamer; Inna A Belyantseva; Meghan C Drummond; Tracy S Fitzgerald; Sarath Vijayakumar; Sherri M Jones; Andrew J Griffith; Thomas B Friedman; Lisa L Cunningham; Wade W Chien
Journal:  Mol Ther       Date:  2017-02-21       Impact factor: 11.454

7.  RNA Interference Prevents Autosomal-Dominant Hearing Loss.

Authors:  Seiji B Shibata; Paul T Ranum; Hideaki Moteki; Bifeng Pan; Alexander T Goodwin; Shawn S Goodman; Paul J Abbas; Jeffrey R Holt; Richard J H Smith
Journal:  Am J Hum Genet       Date:  2016-05-26       Impact factor: 11.025

8.  Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c.

Authors:  Bifeng Pan; Charles Askew; Alice Galvin; Selena Heman-Ackah; Yukako Asai; Artur A Indzhykulian; Francine M Jodelka; Michelle L Hastings; Jennifer J Lentz; Luk H Vandenberghe; Jeffrey R Holt; Gwenaëlle S Géléoc
Journal:  Nat Biotechnol       Date:  2017-02-06       Impact factor: 54.908

9.  Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness.

Authors:  Jennifer J Lentz; Francine M Jodelka; Anthony J Hinrich; Kate E McCaffrey; Hamilton E Farris; Matthew J Spalitta; Nicolas G Bazan; Dominik M Duelli; Frank Rigo; Michelle L Hastings
Journal:  Nat Med       Date:  2013-02-04       Impact factor: 53.440

  9 in total
  2 in total

Review 1.  Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.

Authors:  Michelle L Hastings; Timothy A Jones
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 2.  Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges.

Authors:  Shahar Taiber; Karen B Avraham
Journal:  Neurosci Lett       Date:  2019-10-03       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.